| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Short Communication |
Arbovirus Diseases Branch, Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Service, PO Box 2087, Fort Collins, CO 80522, USA
Correspondence
Wayne D. Crill
wcrill{at}cdc.gov
Human flavivirus infections elicit virus species-specific and cross-reactive immune responses. The flavivirus envelope (E) glycoprotein is the primary antigen inducing protective immunity; however, the presence of cross-reactive antibodies in human sera creates problems for serodiagnosis. Using a West Nile virus-like particle system, we performed mutagenesis across all three E protein functional domains to identify epitope determinants for a panel of monoclonal antibodies (mAbs) raised against different flaviviruses and exhibiting diverse patterns of cross-reactivity. Residues within the highly conserved fusion peptide were the only epitope determinants identified and were important not only for broadly cross-reactive mAbs recognizing all of the medically important flavivirus serocomplexes, but also for less-broad, complex-reactive mAbs. Moreover, different substitutions at specific fusion peptide residues produced highly variable effects on antibody reactivity and virus-like particle secretion. These results support and extend the conclusion that the fusion peptide region constitutes an immunodominant epitope stimulating antibodies with diverse patterns of cross-reactivity.
Primer sequences are available in Supplementary Table S1 in JGV Online.
This article has been cited by other articles:
|
|
 |
|
  S. Kiermayr, K. Stiasny, and F. X. Heinz Impact of Quaternary Organization on the Antigenic Structure of the Tick-Borne Encephalitis Virus Envelope Glycoprotein E J. Virol., September 1, 2009; 83(17): 8482 - 8491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Vogt, B. Moesker, J. Goudsmit, M. Jongeneelen, S. K. Austin, T. Oliphant, S. Nelson, T. C. Pierson, J. Wilschut, M. Throsby, et al. Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step J. Virol., July 1, 2009; 83(13): 6494 - 6507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sultana, H. G. Foellmer, G. Neelakanta, T. Oliphant, M. Engle, M. Ledizet, M. N. Krishnan, N. Bonafe, K. G. Anthony, W. A. Marasco, et al. Fusion Loop Peptide of the West Nile Virus Envelope Protein Is Essential for Pathogenesis and Is Recognized by a Therapeutic Cross-Reactive Human Monoclonal Antibody J. Immunol., July 1, 2009; 183(1): 650 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. I. Falconar Use of synthetic peptides to represent surface-exposed epitopes defined by neutralizing dengue complex- and flavivirus group-reactive monoclonal antibodies on the native dengue type-2 virus envelope glycoprotein J. Gen. Virol., July 1, 2008; 89(7): 1616 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-S. Chiou, W. D. Crill, L.-K. Chen, and G.-J. J. Chang Enzyme-Linked Immunosorbent Assays Using Novel Japanese Encephalitis Virus Antigen Improve the Accuracy of Clinical Diagnosis of Flavivirus Infections Clin. Vaccine Immunol., May 1, 2008; 15(5): 825 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Roberson, W. D. Crill, and G.-J. J. Chang Differentiation of West Nile and St. Louis Encephalitis Virus Infections by Use of Noninfectious Virus-Like Particles with Reduced Cross-Reactivity J. Clin. Microbiol., October 1, 2007; 45(10): 3167 - 3174. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
